Cargando…

Study protocol for connective tissue disease-associated interstitial lung disease trial (TEL-CTD-ILD): A randomized controlled trial of a home-based telemonitoring of treatment effects

INTRODUCTION: Interstitial lung disease is one of the most severe pulmonary complications related to connective tissue diseases, resulting in substantial morbidity and mortality. Telepneumology has the potential to improve the long-term management of patients with CTD-ILD. We propose a randomized co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Małysiak-Szpond, Sylwia, Mozga, Maria, Miądlikowska, Ewa, Miłkowska-Dymanowska, Joanna, Białas, Adam Jerzy, Piotrowski, Wojciech Jerzy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794074/ https://www.ncbi.nlm.nih.gov/pubmed/36574413 http://dx.doi.org/10.1371/journal.pone.0278601

Ejemplares similares

Review: Serum Biomarkers of Lung Fibrosis in Interstitial Pneumonia with Autoimmune Features—What Do We Already Know?
por: Miądlikowska, Ewa, et al.
Publicado: (2021)

The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease
por: Białas, Adam Jerzy, et al.
Publicado: (2016)

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Jee, Adelle S., et al.
Publicado: (2017)

Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study
por: Majewski, Sebastian, et al.
Publicado: (2021)

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
por: Spagnolo, Paolo, et al.
Publicado: (2021)

Vitamin D levels are prognostic factors for connective tissue disease associated interstitial lung disease (CTD-ILD)
por: Gao, Yujuan, et al.
Publicado: (2020)

Underrecognized comorbidities of chronic obstructive pulmonary disease
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2015)

Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers
por: Cerro Chiang, Giuliana, et al.
Publicado: (2023)

The utility of telemedicine in managing patients after COVID-19
por: Bartczak, Krystian T., et al.
Publicado: (2022)

Association of Red Blood Cell Distribution Width Levels with Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
por: Shi, Shenyun, et al.
Publicado: (2021)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
por: Erre, Gian Luca, et al.
Publicado: (2021)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2020)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2022)

Calcium, Phosphate, and Vitamin D Status in Patients with Sarcoidosis—Associations with Disease Activity and Symptoms
por: Gwadera, Łukasz, et al.
Publicado: (2023)

Eosinopenia and neutrophil-to-lymphocyte count ratio as prognostic factors in exacerbation of COPD
por: Karauda, Tomasz, et al.
Publicado: (2021)

Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience
por: Boutel, Maria, et al.
Publicado: (2023)

Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
por: Gagiannis, Daniel, et al.
Publicado: (2020)

Geroprotectors as a therapeutic strategy for COPD – where are we now?
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2017)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2018)

Epithelial Alarmins in Serum and Exhaled Breath in Patients with Idiopathic Pulmonary Fibrosis: A Prospective One-Year Follow-Up Cohort Study
por: Majewski, Sebastian, et al.
Publicado: (2019)

Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study
por: Majewski, Sebastian, et al.
Publicado: (2021)

ChILD – Children's interstitial lung disease
Publicado: (2018)

Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis
por: Majewski, Sebastian, et al.
Publicado: (2022)

Morphometric analysis of mitochondria in lymphocytes of patients with exacerbations of chronic obstructive pulmonary disease – pilot study
por: Białas, Adam J, et al.
Publicado: (2018)

Gender differences in health-related quality of life measured by the Sarcoidosis Health Questionnaire
por: Gwadera, Łukasz, et al.
Publicado: (2021)

Chronotype and the Big-Five personality traits as predictors of chronic fatigue among patients with sarcoidosis. A cross-sectional study
por: Mokros, Łukasz, et al.
Publicado: (2023)

Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry
por: Raghu, Ganesh, et al.
Publicado: (2016)

Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
por: Yamakawa, Hideaki, et al.
Publicado: (2021)

Active Care Management Supported by Home Telemonitoring in Veterans With Type 2 Diabetes: The DiaTel randomized controlled trial
por: Stone, Roslyn A., et al.
Publicado: (2010)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Children’s Interstitial and Diffuse Lung Diseases (ChILD) in 2020
por: Ferraro, Valentina Agnese, et al.
Publicado: (2020)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
por: Copeland, Carla R., et al.
Publicado: (2021)

Outcomes of a telemonitoring-based program (telEPOC) in frequently hospitalized COPD patients
por: Esteban, Cristóbal, et al.
Publicado: (2016)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

An unusual case of interstitial lung disease: Revisiting peribronchiolar metaplasia interstitial lung disease (PBM‐ILD)
por: Jung, Flora, et al.
Publicado: (2023)

Surfactant Metabolism Dysfunction and Childhood Interstitial Lung Disease (chILD)
por: McFetridge, Lynne, et al.
Publicado: (2009)

Soluble ITGaM and ITGb2 Integrin Subunits Are Involved in Long-Term Pulmonary Complications after COVID-19 Infection
por: Siekacz, Kamil, et al.
Publicado: (2023)

Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications
por: Siekacz, Kamil, et al.
Publicado: (2023)

Are There Differences in Inflammatory and Fibrotic Pathways between IPAF, CTD-ILDs, and IIPs? A Single-Center Pilot Study
por: Rzepka-Wrona, Patrycja, et al.
Publicado: (2022)

Mitochondrial functioning abnormalities observed in blood platelets of chronic smoke-exposed guinea pigs – a pilot study
por: Białas, Adam J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gi4lhitbda7jv1dkqgo1oosl02